Advertisement

Topics

Parkinson’s Institute and Clinical Center Company Profile

18:20 EST 19th January 2019 | BioPortfolio

The Parkinson’s Institute and Clinical Center is at the forefront of patient care and therapy development. We are the nation’s only Institute that provides patient care, basic science research, and clinical research in one integrated model. Our unique freestanding organization directly connects research to patient care – from the “bench to bedside.” For 30 years, our team of epidemiologists, physicians, scientists, and therapists, have been at the forefront of every clinical and scientific discovery in the field of Parkinson’s research.


News Articles [2579 Associated News Articles listed on BioPortfolio]

Parkinson’s Institute and Clinical Center and Retrotope Announce Collaboration on New Drug Treatment Therapies for Parkinson’s Disease Patients

SUNNYVALE and LOS ALTOS, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Parkinson’s Institute and Clinical Center, which provides comprehensive patient care, while discovering new treatment options to...

First-ever qualified Parkinson's biomarker is vital step toward improved clinical trials

(Critical Path Institute (C-Path)) The Critical Path Institute's (C-Path) Critical Path for Parkinson's Consortium (CPP), in partnership with Parkinson's UK, announces that the European Medicines Agen...

Barlow Departs Parkinson’s Institute for CMO Post at E-Scape Bio

Carrolee Barlow has joined E-Scape Bio as chief medical officer. Barlow comes to the San Francisco biotech from the Parkinson’s Institute and Clinical Center, where she was CEO. Her experience also ...

Parkinson’s Disease Gene Therapy Clinical Trial Launched in UK

A gene therapy for Parkinson’s disease developed by Swiss biotech Axovant has been used on the first patient in a Phase I/II trial at University College London. Parkinson’s disease is a neurod...

Cooling 'brains on fire' to treat Parkinson's

A promising new therapy to stop Parkinson's disease in its tracks has been developed by scientists who found that a small molecule, MCC950, stopped the development of Parkinson's in several animal mod...

Marmosets serve as an effective model for non-motor symptoms of Parkinson's disease

(Texas Biomedical Research Institute) Small, New World monkeys called marmosets can mimic the sleep disturbances, changes in circadian rhythm, and cognitive impairment people with Parkinson's disease ...

EMA issues positive opinion on biomarker for Parkinson’s trials

Critical Path Institute’s (C-Path) Critical Path for Parkinson’s Consortium (CPP), along with Parkinson’s UK, has announced that the European Medicines...Read More... The post EMA issues positiv...

Parkinson's disease protein buys time for cell repair

(Walter and Eliza Hall Institute) Loss of the protein Parkin causes certain forms of Parkinson's disease, a neurodegenerative condition involving death of neurons.Walter and Eliza Hall Institute resea...

Drugs and Medications [550 Associated Drugs and Medications listed on BioPortfolio]

Exelon [Novartis Pharmaceuticals Corporation]

These highlights do not include all the information needed to use Exelon  Patch safely and effectively. See full prescribing information for Exelon Patch.       Exelon  Patch (rivastig

Pramipexole dihydrochloride [Sandoz Inc]

These highlights do not include all the information needed to use PRAMIPEXOLE DIHYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for PRAMIPEXOLE DIHYDROCHLORIDE TABLETS ....

Pramipexole dihydrochloride [A-S Medication Solutions]

These highlights do not include all the information needed to use PRAMIPEXOLE DIHYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for PRAMIPEXOLE DIHYDROCHLORIDE TABLETS. ...

Pramipexole dihydrochloride [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use PRAMIPEXOLE DIHYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for PRAMIPEXOLE DIHYDROCHLORIDE TABLETS. ...

Pramipexole [Camber Pharmaceuticals, Inc.]

PRAMIPEXOLE DIHYDROCHLORIDE TabletsRx OnlyHIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the information needed to use PRAMIPEXOLE DIHYDROCHLORIDE tablets safely and effectiv...

PubMed Articles [3447 Associated PubMed Articles listed on BioPortfolio]

Validation of the MDS clinical diagnostic criteria for Parkinson's disease.

In 2015, the International Parkinson and Movement Disorder Society published clinical diagnostic criteria for Parkinson's disease. These criteria aimed to codify/reproduce the expert clinical diagnost...

Center of pressure-based balance evaluation in individuals with Parkinson's disease: a reliability study.

The purpose of this study was to assess the test-retest reliability of different balance task outcomes, based on center of pressure (COP) measures in individuals with Parkinson's disease.

PTPRC Expression in Blood is Downregulated in Parkinson's and Progressive Supranuclear Palsy Disorders.

Parkinson's disease (PD) shares pathological and clinical features with progressive supranuclear palsy (PSP) patients making the diagnosis challenging. Distinguishing PD from PSP is crucial given diff...

Pimavanserin use in a movement disorders clinic: a single-center experience.

Parkinson's disease psychosis (PDP) is a disabling non-motor symptom of Parkinson's disease (PD) that is challenging to treat. Dopamine receptor blockers (DRB) are used to treat PDP, though these may ...

Clinical, electrophysiological, and imaging study in essential tremor-Parkinson's disease syndrome.

Essential tremor-Parkinson's disease (ET-PD) syndrome is a clinical condition in which individuals with a long-lasting history of Essential tremor (ET) eventually develop Parkinson's disease (PD). The...

Clinical Trials [5709 Associated Clinical Trials listed on BioPortfolio]

The Clinical Profile of Parkinson Disease in Egypt

Multi-center, retrospective observational cohort study in 4 tertiary referral centers in Cairo over the period from 2004 to 2016. Study population. including all patients with idiopathic ...

Phase 2, Double-Blind, Randomized, Controlled Multi-Center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.

The purpose of this study was to evaluate the differences in safety and efficacy between Parkinson's disease patients who either received transplantation of fetal porcine cells or placebo ...

Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression

This is a observational, multi-center study to assess progression of clinical features, imaging and biologic biomarkers in Parkinson disease (PD) patients compared to healthy controls (HC)...

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

Study participants who have been clinically diagnosed with Parkinson disease will receive no treatment, treatment with either levodopa, or treatment with Mirapex for a period of 12 weeks. ...

Twins and the Risk of Parkinson's Disease: A Clinical and Imaging Study

The purpose of this study is to examine the role of genetic and environmental factors in the cause of Parkinson's disease.

Companies [4208 Associated Companies listed on BioPortfolio]

Parkinson’s Institute and Clinical Center

The Parkinson’s Institute and Clinical Center is at the forefront of patient care and therapy development. We are the nation’s only Institute that provides patient care,...

Amarantus Therapeutics, Inc.

Amarantus Therapeutics, Inc. is a privately-held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death,...

Burnham Institute

The Burnham Institute is an independent, nonprofit, public benefit organization dedicated to basic biomedical research. Founded in 1976, the Institute was originally known as La Jolla Cancer Research ...

The Parkinson Alliance

The Parkinson Alliance is the umbrella organization for the Parkinson's Unity Walk. The Kingston, NJ-based national non-profit organization is dedicated to raising funds to help finance the most promi...

Miami Cancer Institute

Miami Cancer Institute offers comprehensive cancer services and is expanding its clinical services, clinical trials and state-of-the-art technology, including offering the first p...

More Information about "Parkinson’s Institute and Clinical Center" on BioPortfolio

We have published hundreds of Parkinson’s Institute and Clinical Center news stories on BioPortfolio along with dozens of Parkinson’s Institute and Clinical Center Clinical Trials and PubMed Articles about Parkinson’s Institute and Clinical Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Parkinson’s Institute and Clinical Center Companies in our database. You can also find out about relevant Parkinson’s Institute and Clinical Center Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...


Corporate Database Quicklinks



Searches Linking to this Company Record